OCA at 09:28, 2 April 2025

2025-04-02T09:28:07Z

← Older revision		Revision as of 09:28, 2 April 2025
Line 1:		Line 1:
	~~'''Unreleased structure'''~~

	The ~~entry 9ksh~~ is ~~ON HOLD~~ ~~until Paper~~ Publication		==Crystal structure of SARS-CoV-2 main protease in complex with compound 1==
			<StructureSection load='9ksh' size='340' side='right'caption='[[9ksh]], [[Resolution\|resolution]] 1.91Å' scene=''>
			== Structural highlights ==
			<table><tr><td colspan='2'>[[9ksh]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Severe_acute_respiratory_syndrome_coronavirus_2 Severe acute respiratory syndrome coronavirus 2]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=9KSH OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=9KSH FirstGlance]. <br>
			</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models\|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution\|Resolution]] 1.91Å</td></tr>
			<tr id='ligand'><td class="sblockLbl"><b>[[Ligand\|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=A1EGQ:6-[(6-chloranyl-2-methyl-indazol-5-yl)amino]-3-pyridin-3-yl-1-[[2,4,5-tris(fluoranyl)phenyl]methyl]-1,3,5-triazine-2,4-dione'>A1EGQ</scene></td></tr>
			<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=9ksh FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=9ksh OCA], [https://pdbe.org/9ksh PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=9ksh RCSB], [https://www.ebi.ac.uk/pdbsum/9ksh PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=9ksh ProSAT]</span></td></tr>
			</table>
			== Function ==
			[https://www.uniprot.org/uniprot/R1AB_SARS2 R1AB_SARS2] Multifunctional protein involved in the transcription and replication of viral RNAs. Contains the proteinases responsible for the cleavages of the polyprotein.[UniProtKB:P0C6X7] Inhibits host translation by interacting with the 40S ribosomal subunit. The nsp1-40S ribosome complex further induces an endonucleolytic cleavage near the 5'UTR of host mRNAs, targeting them for degradation. Viral mRNAs are not susceptible to nsp1-mediated endonucleolytic RNA cleavage thanks to the presence of a 5'-end leader sequence and are therefore protected from degradation. By suppressing host gene expression, nsp1 facilitates efficient viral gene expression in infected cells and evasion from host immune response.[UniProtKB:P0C6X7] May play a role in the modulation of host cell survival signaling pathway by interacting with host PHB and PHB2. Indeed, these two proteins play a role in maintaining the functional integrity of the mitochondria and protecting cells from various stresses.[UniProtKB:P0C6X7] Responsible for the cleavages located at the N-terminus of the replicase polyprotein. In addition, PL-PRO possesses a deubiquitinating/deISGylating activity and processes both 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains from cellular substrates. Participates together with nsp4 in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication. Antagonizes innate immune induction of type I interferon by blocking the phosphorylation, dimerization and subsequent nuclear translocation of host IRF3. Prevents also host NF-kappa-B signaling.[UniProtKB:P0C6X7] Participates in the assembly of virally-induced cytoplasmic double-membrane vesicles necessary for viral replication.[UniProtKB:P0C6X7] Cleaves the C-terminus of replicase polyprotein at 11 sites. Recognizes substrates containing the core sequence [ILMVF]-Q-\|-[SGACN] (PubMed:32198291). Also able to bind an ADP-ribose-1''-phosphate (ADRP).[UniProtKB:P0C6X7]<ref>PMID:32198291</ref> Plays a role in the initial induction of autophagosomes from host reticulum endoplasmic. Later, limits the expansion of these phagosomes that are no longer able to deliver viral components to lysosomes.[UniProtKB:P0C6X7] Forms a hexadecamer with nsp8 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.[UniProtKB:P0C6X7] Forms a hexadecamer with nsp7 (8 subunits of each) that may participate in viral replication by acting as a primase. Alternatively, may synthesize substantially longer products than oligonucleotide primers.[UniProtKB:P0C6X7] May participate in viral replication by acting as a ssRNA-binding protein.[UniProtKB:P0C6X7] Plays a pivotal role in viral transcription by stimulating both nsp14 3'-5' exoribonuclease and nsp16 2'-O-methyltransferase activities. Therefore plays an essential role in viral mRNAs cap methylation.[UniProtKB:P0C6X7] Responsible for replication and transcription of the viral RNA genome.[UniProtKB:P0C6X7] Multi-functional protein with a zinc-binding domain in N-terminus displaying RNA and DNA duplex-unwinding activities with 5' to 3' polarity. Activity of helicase is dependent on magnesium.[UniProtKB:P0C6X7] Enzyme possessing two different activities: an exoribonuclease activity acting on both ssRNA and dsRNA in a 3' to 5' direction and a N7-guanine methyltransferase activity. Acts as a proofreading exoribonuclease for RNA replication, thereby lowering The sensitivity of the virus to RNA mutagens.[UniProtKB:P0C6X7] Mn(2+)-dependent, uridylate-specific enzyme, which leaves 2'-3'-cyclic phosphates 5' to the cleaved bond.[UniProtKB:P0C6X7] Methyltransferase that mediates mRNA cap 2'-O-ribose methylation to the 5'-cap structure of viral mRNAs. N7-methyl guanosine cap is a prerequisite for binding of nsp16. Therefore plays an essential role in viral mRNAs cap methylation which is essential to evade immune system.[UniProtKB:P0C6X7]
			<div style="background-color:#fffaf0;">
			== Publication Abstract from PubMed ==
			The coronavirus disease 2019 (COVID-19) pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has resulted in millions of deaths and continues to pose serious threats to global public health. The main protease (M(pro)) of SARS-CoV-2 is crucial for viral replication and its conservation, making it an attractive drug target. Here, we employed a structure-based drug design strategy to develop and optimize novel inhibitors targeting SARS-CoV-2 M(pro). By fully exploring occupation of the S1, S2, and S3/S4 binding pockets, we identified eight promising inhibitors with half-maximal inhibitory concentration (IC(50)) values below 20 nM. The cocrystal structure of M(pro) with compound 10 highlighted the crucial roles of the interactions within the S3/S4 pockets in inhibitor potency enhancement. These findings demonstrated that expanding the utilization of these binding pockets was an effective strategy for developing noncovalent small molecule inhibitors that target SARS-CoV-2 M(pro). Compound 4 demonstrated outstanding in vitro antiviral activity against wild-type SARS-CoV-2 with an EC(50) of 9.4 nM. Moreover, oral treatment with compounds 1 and 9 exhibited excellent antiviral potency and substantially ameliorated virus-induced tissue damage in the lungs of Omicron BA.5-infected K18-human ACE2 (K18-hACE2) transgenic mice, indicating that these novel noncovalent inhibitors could be potential oral agents for the treatment of COVID-19.

	~~Authors:~~ Zhong, Y., Zhao, L., ~~Zhang~~, W., ~~Peng, W~~.		Expanding the utilization of binding pockets proves to be effective for noncovalent small molecule inhibitors against SARS-CoV-2 M(pro).,Yang Q, Huang X, Zhang H, Sun J, Tang J, Chen Z, Liu L, Liu M, Sun Z, Tang Z, Wei D, Wang D, Wang Y, Yan M, Zhao L, Zhu A, Zhong Y, Yang H, Zhao Y, Dai J, Shi Y, Huang B, Zhang W, Zhao J, Chen X, Rao Z, Peng W Eur J Med Chem. 2025 May 5;289:117497. doi: 10.1016/j.ejmech.2025.117497. Epub , 2025 Mar 10. PMID:40090296<ref>PMID:40090296</ref>

	~~Description: Crystal structure~~ of ~~SARS~~-~~CoV~~-~~2 main protease in complex with compound 1~~		From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br>
	[[Category: ~~Unreleased~~ Structures]]		</div>
	[[Category: ~~Zhong, Y~~]]		<div class="pdbe-citations 9ksh" style="background-color:#fffaf0;"></div>
	[[Category: Zhang, W]]		== References ==
	[[Category: Zhao, L]]		<references/>
	[[Category: ~~Peng, W~~]]		__TOC__
			</StructureSection>
			[[Category: Large Structures]]
			[[Category: Severe acute respiratory syndrome coronavirus 2]]
			[[Category: Peng W]]
			[[Category: Zhang W]]
			[[Category: Zhao L]]
			[[Category: Zhong Y]]

OCA at 13:01, 1 January 2025

2025-01-01T13:01:12Z

← Older revision		Revision as of 13:01, 1 January 2025
Line 1:		Line 1:
	'''Unreleased structure'''		'''Unreleased structure'''

	The entry 9ksh is ON HOLD		The entry 9ksh is ON HOLD until Paper Publication

	Authors: Zhong, Y., Zhao, L., Zhang, W., Peng, W.		Authors: Zhong, Y., Zhao, L., Zhang, W., Peng, W.
Line 7:		Line 7:
	Description: Crystal structure of SARS-CoV-2 main protease in complex with compound 1		Description: Crystal structure of SARS-CoV-2 main protease in complex with compound 1
	[[Category: Unreleased Structures]]		[[Category: Unreleased Structures]]
			[[Category: Zhong, Y]]
			[[Category: Zhang, W]]
	[[Category: Zhao, L]]		[[Category: Zhao, L]]
	~~[[Category: Zhang, W]]~~
	[[Category: Peng, W]]		[[Category: Peng, W]]
	~~[[Category: Zhong, Y]]~~

OCA: Protected "9ksh" [edit=sysop:move=sysop]

2024-12-11T18:25:04Z

Protected "9ksh" [edit=sysop:move=sysop]

← Older revision	Revision as of 18:25, 11 December 2024
(No difference)

OCA: New page: '''Unreleased structure''' The entry 9ksh is ON HOLD Authors: Zhong, Y., Zhao, L., Zhang, W., Peng, W. Description: Crystal structure of SARS-CoV-2 main protease in complex with compou...

2024-12-11T18:25:02Z

New page: '''Unreleased structure''' The entry 9ksh is ON HOLD Authors: Zhong, Y., Zhao, L., Zhang, W., Peng, W. Description: Crystal structure of SARS-CoV-2 main protease in complex with compou...

New page

'''Unreleased structure'''

The entry 9ksh is ON HOLD

Authors: Zhong, Y., Zhao, L., Zhang, W., Peng, W.

Description: Crystal structure of SARS-CoV-2 main protease in complex with compound 1
[[Category: Unreleased Structures]]
[[Category: Zhao, L]]
[[Category: Zhang, W]]
[[Category: Peng, W]]
[[Category: Zhong, Y]]

9ksh - Revision history

OCA at 09:28, 2 April 2025

OCA at 13:01, 1 January 2025

OCA: Protected "9ksh" [edit=sysop:move=sysop]

OCA: New page: '''Unreleased structure''' The entry 9ksh is ON HOLD Authors: Zhong, Y., Zhao, L., Zhang, W., Peng, W. Description: Crystal structure of SARS-CoV-2 main protease in complex with compou...